key: cord-1055994-70a3gyjb
authors: Mrigpuri, Parul; Gupta, Amitesh; Jha, Ritika; Singla, Pranjal; Singla, Rupak
title: Tobacco use, Tuberculosis and Covid-19: A lethal triad
date: 2021-08-12
journal: Indian J Tuberc
DOI: 10.1016/j.ijtb.2021.08.010
sha: d76a39ed81ced0aa5723723c2af358362403c7d8
doc_id: 1055994
cord_uid: 70a3gyjb

Smoking, TB and Covid-19 are high prevalence entities with public health consequences. All three of them have a possible complex interaction at cellular level. Smoking behavior makes it difficult to maintain infection control measures. Smoking is known to increase TB infection and also adversely affect treatment outcomes in TB. There is also upcoming evidence which suggests that smoking and TB increase the risk of severe Covid-19 symptoms. Simple infection control measures like, social distancing, cough etiquette, isolation, hand hygiene, quarantine, use of masks etc. play a pivotal role in prevention of these diseases. There is need of strengthening of the public health policies and incorporation of the Covid-19 safety awareness measures into the various national programmes.

Smoking is known to increase the risk of various other infections. Risk for pneumococcal, legionella, and mycoplasma pneumonia infection is about 3-5-times higher in smokers than non-smokers. Studies though scarce have shown increased risk of mortality and increased disease severity in smokers with Middle Eastern respiratory syndrome coronavirus. 5 It also hinders the cytokine release and results in upregulation of the angiotensin converting enzyme 2 (ACE-2) receptor, which is the main receptor used by SARS-CoV-2 for entry to the mucosa. 5 SARS-CoV-2 infection has been implicated in the reactivation of dormant TB by activating the cell mediated defence mechanism and its role in predisposing for TB is also proposed in view of its ability to initiate inflammation by increasing cytokine release. Moreover, the virus affects the host immunity because of mutations in Interferon-γ and Interleukin-12 signaling pathways. 6 J o u r n a l P r e -p r o o f

Smoking is a known risk factor for getting infected with Mycobacterium tuberculosis and developing a severe form of the disease. It has also been linked to poor TB treatment outcomes. 4 Smokers have been found to be more likely to contract the flu and smoking has been found to be consistently associated with a higher risk of hospital admissions after influenza infection. Smoking is also primary etiological factor behind chronic obstructive pulmonary diseases (COPD) and exacerbations of COPD are strongly linked to respiratory viruses. 5 Some studies have shown smoking to be associated with severe Covid-19. 7 While one meta-analysis did not associate smoking with severity of coronavirus disease. 8 Smoking is not yet established as a risk factor for acquiring SARS-CoV-2 infection, but it might increase the disease severity. Also, smoking is an established causative factor for many chronic diseases which are themselves a risk factor for increased disease severity in Covid-

The co-existence of Covid-19 and TB pandemic had given rise to various concerns. Firstly, as both primarily affect lungs leading to overlapping symptoms, there were concerns about a diagnostic difficulty. Secondly, there was worry regarding delay in TB diagnosis and treatment because of Covid-19 restrictions and lockdown. Number of patients registered for TB treatment and notification of cases declined. To combat the effects of the pandemic on tuberculosis services in India National TB Elimination Program (NTEP) announced a rapid response plan and a plan for bi-directional screening. Under this all diagnosed patients with TB are to be screened for Covid-19, and all Covid-19-positive patients are to be screened for TB. 9 Thirdly, there was apprehension regarding increased disease severity and mortality. The frequent use of drugs like Tocilizumab further complicated the situation as it reduces the macrophage and cytotoxic cell differentiation thus leading to decreased anti-mycobacterial activity. 6 Currently available evidence is insufficient to support that TB increases the susceptibility to Covid-19 but evidence support that TB may lead to increased risk of complications from Covid-19. 6 Preventive strategies and suggestions J o u r n a l P r e -p r o o f Both TB and Covid-19 are known to spread to contacts through droplet nuclei of aerosols.

Thus, simple infection control measures like, social distancing, cough etiquette, isolation, hand hygiene, quarantine, use of masks etc. play a pivotal role in prevention of these diseases. 6 

WHO report on the global tobacco epidemic 2019: offer help to quit tobacco use

091 Cases and 4,234,090 Deaths from the Coronavirus -Worldometer

Association between tuberculosis and smoking

Tobacco smoking and COVID-19 infection

Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: convergence can be fatal. Monaldi Arch Chest Dis

The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis. Pulmonary Medicine

Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)

India's syndemic of tuberculosis and COVID-19

COVID-19 and Smoking: What Evidence Needs Our Attention? Front Physiol